StockWatch
·
Pharmaceutical Preparations
DelistingNov 4, 2026, 05:32 PM

Bio Green Med Solution Receives Nasdaq Delisting Warning

AI Summary

Bio Green Med Solution, Inc. received a notification from Nasdaq indicating that its common stock has not met the minimum bid price requirement of $1.00 for 30 consecutive business days. The company has been granted a 180-day grace period, until April 27, 2027, to regain compliance. During this period, the stock will continue to trade on The Nasdaq Capital Market. The company is exploring options to regain compliance, including a potential reverse stock split, which is also part of a proposed business combination with Future NRG Sdn. Bhd. If compliance is not achieved, the stock may be subject to delisting.

Key Highlights

  • Bio Green Med Solution, Inc. received a notice from Nasdaq for failing to meet the minimum bid price requirement of $1.00.
  • The company has 180 days, until April 27, 2027, to regain compliance by having its stock close at or above $1.00 for 10 consecutive business days.
  • Failure to comply may result in the delisting of the Common Stock from The Nasdaq Capital Market.
  • The company is considering a reverse stock split as part of a business combination with Future NRG Sdn. Bhd. to address the bid price issue.